Dopaminergic Control of the Neurotransmitter Release in the Subthalamic Nucleus: Implications for Parkinson’s Disease Treatment Strategies

kod QR

Dopaminergic Control of the Neurotransmitter Release in the Subthalamic Nucleus: Implications for Parkinson’s Disease Treatment Strategies

None

Zapisane w:

Opis bibliograficzny
Główni autorzy:	Ampe, Ben, Arfani, Anissa El, Michotte, Yvette, Sarre, Sophie
Format:	Elektroniczne Rozdział
Język:	angielski
Wydane:	IntechOpen 2011
Hasła przedmiotowe:	Health Sciences
Dostęp online:	https://www.intechopen.com/chapters/21583
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

Cognitive and Behavioural Changes After Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
od: Daniele, Antonio, i wsp.
Wydane: (2012)

Nucleus Basalis of Meynert Volume and Cognitive Impairment in Parkinson’s Disease Before and After Deep Brain Stimulation of the Subthalamic Nucleus
od: Vibuthi Sisodia, i wsp.
Wydane: (2025-06-01)

Targeting the Subthalamic Nucleus for Deep Brain Stimulation in Parkinson Disease: The Impact of High Field Strength MRI
od: Winkler, Dirk, i wsp.
Wydane: (2012)

Mechanisms of High Frequency Stimulation of the Subthalamic Nucleus in Parkinson's Disease: From Local to Distal Effects on the Basal Ganglia Network
od: Savasta, Marc, i wsp.
Wydane: (2011)

Unconsciousness reshapes the oscillatory topography of the subthalamic nucleus: A comparative study
od: Laura Dubach, i wsp.
Wydane: (2025-09-01)

Mesothalamic Dopaminergic Activity: Implications in Sleep Alterations in Parkinson's Disease
od: Madureira, Daniele Q. M.
Wydane: (2011)

Dystonia and Dopaminergic Therapy: Rationale Derived from Pediatric Neurotransmitter Diseases
od: Fujioka, Hiroki
Wydane: (2012)

Genetic features of the dopaminergic neurotransmitter system in patients with alcohol dependence and depression comorbidity
od: A. E. Nikolishin, i wsp.
Wydane: (2019-12-01)

Pathophysiology of Non-Dopaminergic Monoamine Systems in Parkinson's Disease: Implications for Mood Dysfunction
od: Bhide, Nirmal, i wsp.
Wydane: (2011)

Effect of subthalamic deep brain stimulation on gait in patients with advanced Parkinson’s disease
od: Juan F. Mier-García, i wsp.
Wydane: (2025-07-01)

Psychiatric Outcomes of Subthalamic Nucleus Deep Brain Stimulation: A Systematic Review of Short- and Long-Term Effects
od: Mattia Vittorio Pomes, i wsp.
Wydane: (2025-05-01)

Facilitation of Neurotransmitter and Hormone Release by P2X Purinergic Receptors
od: Vavra, Vojtech, i wsp.
Wydane: (2012)

Corrigendum to “Subthalamic nucleus deep brain stimulation for patients with Parkinson's disease: comparison of active contact selection by clinical test vs beta band brain sensing” [Brain Stimul 18 (1) (2025) 406]
od: Matthias S.C. Chan, i wsp.
Wydane: (2025-07-01)

TAAR8 in the Brain: Implications for Dopaminergic Function, Neurogenesis, and Behavior
od: Taisiia S. Shemiakova, i wsp.
Wydane: (2025-06-01)

A case report: combined posterior subthalamic area and globus pallidus internus deep brain stimulation in Parkinson’s disease
od: Qi Deng, i wsp.
Wydane: (2025-07-01)

Cancer and neurotransmitter receptors
od: Xiaoqiang Wang, i wsp.
Wydane: (2025-07-01)

Deep brain stimulation of pallidal versus subthalamic for patients with Parkinson&#39;s disease: a meta-analysis of controlled clinical trials
od: XU F, i wsp.
Wydane: (2016-06-01)

Nucleus accumbens dopamine release reflects Bayesian inference during instrumental learning.
od: Albert J Qü, i wsp.
Wydane: (2025-07-01)

Neurotransmitter and Behaviour: Serotonin and Anxiety
od: Rex, André, i wsp.
Wydane: (2011)

Proteomic insights into the biology of dopaminergic neurons
od: Claudia Cavarischia-Rega, i wsp.
Wydane: (2025-07-01)

Stress in Fish: Neuroendocrine and Neurotransmitter Responses
od: Mingzhe Yuan, i wsp.
Wydane: (2025-06-01)

The Dissociation of Latrophilin Fragments by Perfluorooctanoic Acid (PFOA) Inhibits LTX<sup>N4C</sup>-Induced Neurotransmitter Release
od: Evelina Petitto, i wsp.
Wydane: (2025-07-01)

Sympathetic Neurotransmitters in Neuroblastoma – Between Physiology and Pathology
od: Czarnecka, Magdalena, i wsp.
Wydane: (2012)

INHIBITORY NEUROTRANSMITTERS AND THEIR INFLUENCE ON TUMOR IN PATIENTS WITH GLIOMAS
od: A. V. Kartashev, i wsp.
Wydane: (2016-02-01)

Amino acid neurotransmitters in sarcopenia and healthy aging
od: Steffi M. Jonk, i wsp.
Wydane: (2025-09-01)

Divide and Conquer: Automatic Detection of the Thalamus to Empower DBS Physiological Navigation to the Subthalamic Region
od: Stefanie Glowinsky, i wsp.
Wydane: (2025-01-01)

Neurotoxic Effects of Triazole Fungicides on Nigrostriatal Dopaminergic Neurotransmission
od: Faro, Lilian Rosana
Wydane: (2010)

Actions of GDNF on Midbrain Dopaminergic Neurons: The Signaling Pathway
od: Gao, Dianshuai, i wsp.
Wydane: (2011)

Pacemaker Currents in Dopaminergic Neurones of the Mice Olfactory Bulb
od: Pignatelli, Angela, i wsp.
Wydane: (2012)

The atom and its nucleus /
od: Gamow, George
Wydane: (1961)

Introduction to the atomic nucleus /
od: Cuninghame, J. G.
Wydane: (1964)

Directed Mutagenesis in Structure Activity Studies of Neurotransmitter Transporters
od: Carland, Jane E., i wsp.
Wydane: (2013)

Phthalocyanine-Modified Electrodes Used in the Electroanalysis of Monoamine Neurotransmitters
od: Anton Alexandru Ciucu, i wsp.
Wydane: (2025-07-01)

Gut microbiota and stress ulcers: unraveling the neurotransmitter connection
od: Khaled A. Abdel-Sater, i wsp.
Wydane: (2025-07-01)

Deep brain stimulation in globus pallidus internus travels to thalamus and subthalamic nuclei along physiological pathways
od: Maral Kasiri, i wsp.
Wydane: (2025-07-01)

Investigation of the Chemical Composition and Dopaminergic Activity of the Vitex Agnus-castus Fruits
od: G. V. Adamov, i wsp.
Wydane: (2020-08-01)

Comparison of AAV Serotypes for Gene Delivery to Dopaminergic Neurons in the Substantia Nigra
od: Korecka, Joanna, i wsp.
Wydane: (2011)

The role of brain dopaminergic system in forming of EEG biofeedback sessions effects
od: Yu. O. Fokina, i wsp.
Wydane: (2010-04-01)

Serotonergic and Dopaminergic Function in Neuropsychiatrically Asymptomatic People With HIV on Antiretroviral Therapy
od: Chuen‐Yen Lau, i wsp.
Wydane: (2025-07-01)

Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function
od: Takeyoshi K, i wsp.
Wydane: (2016-03-01)